Background: Retatrutide (RETA) is a single peptide with agonist activity at GIR, GLP-1, and glucagon receptors, which demonstrated clinically meaningful glucose- and body weight-lowering efficacy in ...participants with type 2 diabetes (T2D). Quality of weight loss is an important consideration in this setting. Here, we analyze the change in body composition (BC) and the ratio of absolute fat mass loss (FML) to absolute total body mass loss (TBML) after 36 weeks treatment with RETA. Methods: The phase 2, randomized double-blind study included adults with T2D. Participants received once weekly RETA 0.5, 4, 8, or 12 mg, dulaglutide 1.5 mg (DULA) or PBO. Change from baseline in TBM and BC at week 36 was assessed. The ratio of FML to TBML was assessed in treatment groups with mean TBML >5 kg (RETA 4, 8, 12 mg). On treatment data prior to discontinuation of study drug and regression methods were used for analysis. Results: 189 subjects were enrolled in the dual X-ray absorptiometry (DXA) sub-study and 103 had baseline and postbaseline DXA data with 13-22 in all the treatment arms. Overall baseline characteristics (55.6% female, mean age 56.0 years, BMI 35.2 kg/m2, TBM 97.0 kg, HbAlc 8.3%) were similar to those of the main study as was weight loss across the study arms. The percent reduction from baseline in TBM was 2.6%, 9.7%, 17.1%, 16.0%, 1.0%, 2.4% with RETA 0.5, 4, 8, 12 mg, DULA and PBO respectively. There was 4.9%, 15.2%, 26.1%, 23.2%, 2.6%, 4.5% percent reduction in fat mass in RETA 0.5, 4, 8, 12 mg, DULA and PBO respectively. There was 0.9%, 6.0%, 12.5%, 11.7%, -0.7%, 1.3% percent reduction in lean mass in RETA 0.5, 4, 8, 12 mg, DULA and PBO respectively. The percent body fat was significantly decreased only in the RETA arms. The ratio of FML to TBML was 0.67 in a pooled analysis of the RETA 4 mg, 8 mg, and 12 mg arms. Conclusions: In adults with T2D, RETA treatment led to improvements in body composition. The ratio of fat mass loss to total body mass loss was consistent with other weight loss regimens.
Background: Three-dimensional optical (3DO) body composition (BC) from statistical shape models have been developed and vali- dated on cross-sectional data. This technique has shown to be ac- curate ...and precise in respect to dual-energy X-ray absorptiometry (DXA). However, it is unknown if 3DO is sensitive enough to detect change in BC. Therefore, our objective was to evaluate the accuracy of the previously developed cross-sectional models for detecting change and the need for new longitudinal models. Methods: Data from participants in the longitudinal arm of the Shape Up! Adults, FB4 Study, and Louisiana State University Athlete's Study were used in this analysis. Measures on all partici- pants included 3DO and DXA scans at baseline and follow-up using similar make and model systems. Healthy participants went through study-specific interventions that included either dietary or physical activity modifications. Fat mass (FM) and visceral adipose tissue (VAT) were estimated from 3DO scans using previously-developed statistical shape models. Changes in these estimates were compared to criterion changes in DXA. Further, fundamental studies relating change in shape and demographics to DXA were performed using step-forward linear regression with 5-fold cross-validation. Results: For this analysis, 107 participants completed the study (males = 67). Of the models created, 3DO estimates of FM from the previ- ously developed cross-sectional model performed the best for females (R2 = 0.88, RMSE = 1.29 kg) while fundamental models of change in shape were best for males (R2 = 0.88, RMSE = 1.8 kg). Change in DXA VAT for both males and females was best predicted by change in shape models (R2 = 0.57 and 0.49, RMSE = 85 g and 76 g, respectively). Conclusions: Using a diverse population of healthy males and females, various 3DO models accurately estimated changes in DXA FM and VAT over time.
Background: Bariatric surgery remains the most effective method for weight loss and mitigation of comorbid conditions for obese patients. Early post-operative weight loss is rapid and slowly levels ...off, creating characteristic asymptotic weight loss curves. Little is known with regard tto the relative degrees of fat free mass (FFM) loss versus fat mass (FM) loss in this early period. Ideally, weight loss methods including bariatric surgery will provide FM loss that is much greater than FFM loss, thus preserving lean body mass. We sought to better characterize the patterns of early weight loss after bariatric surgery. Methods: Retrospective chart review of patients who had bariatric surgery at our institution between March 2019 and November 2022 was performed. A total of 184 patients underwent sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB) or Biliopancreatic Diversion with Duodenal Switch (BPD/DS). Body composition analysis was performed using bioimpedance methods with a medical body composition analyzer. The following values were obtained for each patient: fat free mass (FFM), fat mass (FM) and total weight (WT). Data was collected pre-surgery and in post-surgery follow up at 2 weeks-1 month, 2-4 months and 5-7 months. Results: The highest rates of FFM loss were found in the first 2 weeks post-bariatric surgery (p < 10e-7, 95%CI 10.5-17.9). FFM and FM loss showed no significant difference within the initial 2 weeks postsurgery (p = 0.74). Following the initial 2 months post-surgery, FFM rates slowed down significantly. FM loss rates continued to progress after the initial 2 weeks compared to FFM loss. Significant differences between FFM and FM loss were seen at 2-4 months (p = 1.0e-09, 95% Cl5.8-9.1) and 5-7 months post-surgery (p = 5.1e-08, 95% Cl 1.6-5.5). The RYGB procedure showed significantly more mean FFM loss within the first 2 weeks compared to patients who underwent SG (RYGB = 7.54, SG = 5.82, p = 0.04678, 95%CI 0.03-3.4). No difference was seen after this. No other significant differences were seen based on surgical procedure. Long term weight loss is not impacted by early excessive FFM. Conclusions: FFM loss is highest in the first 2 weeks post-surgery. FM loss predominated subsequently. Overall weight loss is not significantly impacted by excessive FFM loss. FFM loss is short-term. Type of procedure only affects early FFM loss.
Background: Measuring body composition in a seated position would be advantageous in clinical practice because patients are already seated while waiting in patient rooms. This allows sufficient time ...for fluid shifts to occur that can affect bioelectrical impedance analysis (BIA). However, BIA's assumption of a uniform cylindrical shape may be violated in the seated position if the trunk contacts the limbs, such as in people with a high waist circumference (WC). The aims of this research are to determine whether posture (supine, standing, and seated) and WC affect agreement of fat-free mass (FFM) as measured by BIA and DXA. Methods: Data were collected from 28 adults (mean = 61.2 ± 6.9 years, 64.3% female) with obesity (BMI 38.6 ± 5.0 kg/m2). FFM was measured by BIA in the supine, standing, and seated positions and by DXA while supine. Interclass correlation coefficient (ICC) analyses with two-way mixed effects and absolute agreement were performed to determine agreement. Results: Point estimates of agreement between BIA and DXA FFM measures were excellent in supine (ICC = 0.93, 0.75-0.97 95% Cl), and good in standing (ICC = 0.89, 0.31-0.97) and seated (ICC = 0.77, 0.12-0.92) positions. Better agreement was observed across all positions in participants with a WC below the median (118.3 cm) compared to above the median (supine: 0.97 0.90-0.99 vs. 0.87 0.780.96, standing: 0.92 0.20-0.98 vs. 0.83 0.16-0.95, seated: 0.86 -0.02-0.97 vs. 0.65 0.00-0.89). Regardless of WC, measuring FFM by BIA in the supine position resulted in the narrowest 95% confidence intervals. Conclusions: Despite the potential pragmatic value of measuring BIA in a seated position, results of this analysis demonstrate the poorest DXA-BIA agreement with that method that was accentuated in people with high WC. The observed excellent agreement and narrow confidence intervals-regardless of WC-indicate that a supine position should be recommended when using BIA to measure body composition.
Background: Previous studies have shown that lipid accumulation in the liver, as seen in obese individuals, is associated with depolarization of hepatocytes. Hepatocyte depolarization has been shown ...to cause changes in hepatic vagal afferent nerve (HVAN) firing rate, a key component in food intake regulation. However, it is not well understood how hyperpolarization of hepatocytes impacts energy homeostasis. In this study, we assessed the impact of chronic hyperpolarization, through the overexpression of potassium inward rectifying channel 2.1 (KCNJ2) in hepatocytes on basal energy expenditure (EE) in thermoneutral housing temperatures. Methods: Male C57Bl/6J were placed on a low-fat diet and given either AAV-TBG-GFP or AAV-TBG-KCNJ2 intraperitoneal injections. 6-weeks post injection mice were placed in an indirect calorimetry system and energy expenditure, body weight, body composition, and food intake were recorded over 1-week. Results: There was no significant difference in body weight, body composition, or food intake. Interestingly, total EE was significantly higher in KNCJ2 mice compared to GFP, which was driven by increased nonresting EE and not resting EE. As such, activity EE and cage activity was significantly greater in the KCNJ2 mice. Additionally, there was no significant difference in the respiratory quotient or the thermic effect of food. Concluslons: Together these data show that the hyperpolarization of hepatocytes results in increased activity and total EE and shows that hepatocyte polarization is an important factor in energy homeostasis and merits further investigation.
Background: Body composition provides important information about individual risk for chronic disease. Dual Energy X-ray Absorptiometry (DXA) and isotopic dilution technique using deuterium oxide ...(D2O) are widely accepted as the gold standard methods for estimating total fat mass and total body water (TBW), respectively. Both methods are expensive and require trained personnel for execution. Bioelectrical impedance analyzers (BIAs) like InBody 770 (IB770) which use a low-frequency electrical current to estimate total body water, regional and total body fat and lean mass. The objective of this study was to test and report the validity of research grade BIA, the IB770 body composition measures against the cold standard techniques. Methods: Fifty-five women (21.1±2.6 years, BMI: 25.8±5.5 kg/m2, 40% African American) were evaluated using IB770, DXA, and D2O. Measures of TBW, regional (arms, trunk, and legs) and total fat masses (TFM), and regional and total lean body masses (LBM) were calculated. Correlation analysis was used to verify body composition measures between devices. Agreement was determined by examining relationships between the differences in and averaged body composition measured on each method. Results: TBW measured by the IB770 and D2O were correlated (p=0.97; p<0.001). We also found positive correlations for measurements of LBM (p=0.97; p<0.001), TFM (p=0.99; p<0.001), regional fat mass of arms (p=0.95; p<0.001), legs (p=0.91; p<0.001), and trunk (p=0.98; p<0.001) when measured by IB770 and DXA. Arms, trunk, and legs lean masses measured by IB770 and DXA were not associated (p>0.05). The lack of a significant relationship between the difference and average TBW measured by IB770 and D20 (p=-0.07; p=0.608) indicates a good agreement between the two. The relationship between the difference and average total lean body mass (p=0.13; p=0.348) and trunk fat mass (p =0.01; p=0.935) did not differ using IB770 and DXA, indicating that these are devices are in agreement. Significant differences were found in the relationship between the difference and average for total, arms and legs fat masses measured by IB770 and DXA, showing that these are devices are not in agreement for these body composition measures. Conclusions: IB770 showed agreement with D2O and can be used interchangeably for TBW. IB770 can also be used in place of DXA for lean body mass and trunk fat mass.
